BIO

BIO RAD LABS INC

7 superinvestors own BIO

Based on latest 13F filings — data is 45–90 days delayed

Investor	Fund	Weight	Shares	Value	Quarter	Activity
Ariel Investments	Ariel Investments (Bobrinskoy & Rogers)	2.45%	785,961	$219.1M	2026Q1	Added
Mason Hawkins	Longleaf Partners – Southeastern Asset Management	2.23%	162,804	$45.4M	2026Q1	Reduced
First Eagle Investment Management	First Eagle Investment Management	0.96%	2,602,772	$725.5M	2026Q1	Added
FPA / Steven Romick	FPA Crescent Fund – First Pacific Advisors	0.67%	478,900	$33.9M	2006Q3	Reduced
Bill Nygren	Oakmark Select Fund – Harris Associates	0.05%	24,500	$2.0M	2008Q2	Reduced
Kenneth Fisher	Fisher Asset Management	0.01%	118,683	$33.1M	2026Q1	Reduced
Meridian / ArrowMark	Meridian Contrarian Fund	0.00%	9	$1K	2016Q3	New

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

What Is SEC Form 4?

Understand the insider trade filings behind BIO activity.

What Is a 13F Filing?

How superinvestors disclose their quarterly holdings.

Insider Cluster Buying

Why multiple insiders buying together is a strong signal.

Superinvestor Consensus

The most widely held stocks across all tracked institutions.